Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
9,300.00
+100.00 (1.09%)
Mar 20, 2026, 10:10 AM KST
185.28% (1Y)
| Market Cap | 254.63B +166.3% |
| Revenue (ttm) | 108.14B +5.8% |
| Net Income | 1.41B |
| EPS | 60.34 |
| Shares Out | 27.68M |
| PE Ratio | 152.47 |
| Forward PE | n/a |
| Dividend | 30.00 (0.32%) |
| Ex-Dividend Date | Mar 3, 2026 |
| Volume | 391,609 |
| Average Volume | 1,278,875 |
| Open | 9,200.00 |
| Previous Close | 9,200.00 |
| Day's Range | 9,160.00 - 9,670.00 |
| 52-Week Range | 2,995.00 - 15,960.00 |
| Beta | 0.79 |
| RSI | 38.18 |
| Earnings Date | n/a |